With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech Pharmaceuticals is on the verge of making its commercial debut. The FDA last week ...
CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced that the U.S. Food and ...
Neurotech’s Encelto is surgically implanted and delivers genetically modified cell therapy to the eye Neurotech Pharmaceuticals Inc.’s research efforts are paying off. The biotech company, focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback